DENTSPLY SIRONA Inc
NASDAQ:XRAY
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 12.2 | ||
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 23.4 | ||
CH |
Alcon AG
SIX:ALC
|
35.5B CHF | 17.8 | ||
DK |
Coloplast A/S
CSE:COLO B
|
194.1B DKK | 26.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 27.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.7B USD | 22.3 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.3T KRW | -123.3 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.1B CNY | 29 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 46.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 15.8 | |
CH |
Ypsomed Holding AG
SIX:YPSN
|
4.6B CHF | 30.2 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.